Clinical and Dermoscopic Evaluation to study the Effectiveness of Metformin vs Pioglitazone in Acanthosis Nigricans – A Randomized Control Trial

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1760

Full metadata record

DC Field	Value	Language
dc.contributor.author	REG NO: BT0121001	-
dc.date.accessioned	2025-04-25T12:09:11Z	-
dc.date.available	2025-04-25T12:09:11Z	-
dc.date.issued	2024	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/1760	-
dc.description.abstract	ABSTRACT Background and Objectives: Acanthosis Nigricans (AN) is defined by thick, hyperpigmented skin of flexural areas, often indicating underlying systemic conditions like metabolic syndrome. Its prevalence is escalating, notably reaching 6.5% in India. AN severity correlates with insulin resistance, emphasizing the importance of addressing underlying conditions. Dermoscopic examination aids diagnosis by revealing characteristic features. Metformin and pioglitazone are commonly used for insulin resistance in AN, yet comparative efficacy data is lacking. This study evaluates the clinical improvement, metabolic profile, and dermoscopic changes in patients of AN treated with metformin and pioglitazone.	en_US
dc.language.iso	en_US	en_US
dc.publisher	KLE Academy of Higher Education and Research, Belagavi	en_US
dc.title	Clinical and Dermoscopic Evaluation to study the Effectiveness of Metformin vs Pioglitazone in Acanthosis Nigricans – A Randomized Control Trial	en_US
dc.type	Dissertations	en_US
Appears in Collections:	Dermatology, Venereology & Leprosy MD

Files in This Item:

File	Description	Size	Format
BT0121001.pdf		5.66 MB	Adobe PDF	View/Open